Evidence map›Paper›PMID 27795802›Full record

ArticleThe Pan African medical journal2016

Intravenous thrombolysis with rt-PA in stroke: experience of the moroccan stroke unit.

Naima Chtaou, Lamyae Rachdi, Aouatef El Midaoui, Zouhair Souirti, Nils Wahlgren, Mohammed Faouzi Belahsen

Open access · goldAbstract read
In one paragraph

Article in The Pan African medical journal, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 2 pooled it
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 2 syntheses or guidelines pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Naima ChtaouNeurology Department, Hassan II University Hospital, Fez, Morocco.
Lamyae RachdiNeurology Department, Hassan II University Hospital, Fez, Morocco.
Aouatef El MidaouiNeurology Department, Hassan II University Hospital, Fez, Morocco; Laboratory of Epidemiology and Public Health, Faculty of Medicine and Pharmacy, Sidi Mohammed BenAbdellah university Fez, Morocco.
Zouhair SouirtiNeurology Department, Hassan II University Hospital, Fez, Morocco.
Nils WahlgrenDepartment of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Mohammed Faouzi BelahsenNeurology Department, Hassan II University Hospital, Fez, Morocco; Laboratory of Epidemiology and Public Health, Faculty of Medicine and Pharmacy, Sidi Mohammed BenAbdellah university Fez, Morocco.
Centre Hospitalier Universitaire Hassan II · MAKarolinska Institutet · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The majority of strokes are due to blockage of an artery in the brain by a blood clot. Prompt treatment with thrombolytic drugs can restore blood flow before major brain damage has occurred. We report the case series of all patients who were treated with rt-PA at Stroke Unit of HASSAN II University hospital between 2010 and 2013. There were 52 patients treated with intravenous rtPA during the study period. The mean age was 63 years with the no gender predominance (sex ratio 1.02). Hypertension was the most common vascular risk factor (31%) and 17% of patients suffered from atrial fibrillation. 17 of 52 patients (32.7%) were treated within a 3 hours window of stroke onset and 35 of 52 (67.3%) patients were treated within 3-4.5 h. Twenty five patients (48%) had significant early improvements within 24 hours and twenty one (40.3%) patients had good outcomes at 3 months and fifteen patients (29%) died within the same period.

Indexed as

Administration, IntravenousAtrial FibrillationBrain IschemiaFemaleFibrinolytic AgentsHumansHypertensionMaleMiddle AgedMoroccoRisk FactorsStrokeTime FactorsTissue Plasminogen ActivatorTreatment OutcomeFibrinolytic AgentsTissue Plasminogen ActivatorIntravenous thrombolysisrt-PAstroke

Identifiers

PMID27795802
PMCPMC5072866
OpenAlexW2467284922

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.